NewGenIvf Group Limited Class A Ordinary Shares Cash Flow Conversion Efficiency
NewGenIvf Group Limited Class A Ordinary Shares cash flow conversion efficiency. Based on the latest financial reports, NewGenIvf Group Limited Class A Ordinary Shares (NIVF) has a cash flow conversion efficiency ratio of 4.973x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.35 Million) by net assets ($-1.28 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of NewGenIvf Group Limited Class A Ordinary Shares (2021–2025)
Cash flow conversion efficiency of NewGenIvf Group Limited Class A Ordinary Shares from 2021 to 2025. This chart illustrates how NewGenIvf Group Limited Class A Ordinary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data. View NIVF live share price for real-time trading data and today's change.
NewGenIvf Group Limited Class A Ordinary Shares Cash Flow Conversion Ratio Explained
NewGenIvf Group Limited Class A Ordinary Shares cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
NewGenIvf Group Limited Class A Ordinary Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NewGenIvf Group Limited Class A Ordinary Shares ranked by their cash flow conversion efficiency. Also see NIVF company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Candela Invest SA
BR:CAND
|
0.050x |
|
Lucapa Diamond Co Ltd
F:NHY
|
-0.007x |
|
Stinger Resources Inc
V:STNG
|
-0.044x |
|
Digjam Limited
NSE:DIGJAMLTD
|
-0.688x |
|
Global Battery Metals Ltd
V:GBML
|
-0.020x |
|
Clearside Biomedical Inc
NASDAQ:CLSD
|
0.102x |
|
Fonix Mobile plc
LSE:FNX
|
1.074x |
|
SRT Marine Systems plc
LSE:SRT
|
-0.305x |
Annual Cash Flow Conversion Efficiency for NewGenIvf Group Limited Class A Ordinary Shares (2021–2025)
The table below shows the annual cash flow conversion efficiency of NewGenIvf Group Limited Class A Ordinary Shares from 2021 to 2025. Review NIVF cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $25.99 Million | $-10.93 Million | -0.420x | -107.54% |
| 2024-12-31 | $-1.48 Million | $-8.26 Million | 5.577x | +10245.75% |
| 2023-12-31 | $15.60 Million | $-857.36K | -0.055x | +98.95% |
| 2022-12-31 | $100.68K | $-527.12K | -5.235x | -234.26% |
| 2021-12-31 | $-914.91K | $1.43 Million | -1.566x | -- |
About NewGenIvf Group Limited Class A Ordinary Shares
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screen… Read more